Coherus Oncology (CHRS) Receivables (2013 - 2026)
Coherus Oncology's Receivables came in at $14.25 million for Q2 2026, down 88.1% from $119.64 million a year earlier and down 36.7% from the prior quarter.
Powered by 
Analysis
Coherus Oncology (CHRS) Receivables (2013 - 2026) Analysis & Trends
At the end of FY2025, Coherus Oncology's Receivables was $18.42 million, down 84.9% from FY2024.
- Receivables carries a five-year compound annual growth rate of -34.9% (FY2020 to FY2025).
- Going back by year, Receivables was $122.33 million in FY2024 (-53.0%), $260.52 million in FY2023 (+136.9%), $109.96 million in FY2022 (-10.6%) and $123.02 million in FY2021 (-21.7%).
- The Q2 2026 figure represents the lowest quarterly Receivables since Q1 2017.
- Year-over-year, Receivables has declined for three consecutive quarters, with an average decline of 51.5% over the last eight quarters.
- The fastest year-over-year change in Receivables over five years came in Q1 2024 (growth of 180.1%), and the weakest in Q2 2026 (a decline of 88.1%).
- Business Quant data shows CHRS's Receivables at $22.51 million (Q1 2026), $18.42 million (Q4 2025) and $250.5 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Coherus Oncology | 155.59 Mn | -480.55 Mn | 10.07 Mn | 14.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.25 Mn |
| Mar 31, 2026 | 22.51 Mn |
| Dec 31, 2025 | 18.42 Mn |
| Sep 30, 2025 | 250.50 Mn |
| Jun 30, 2025 | 119.64 Mn |
| Mar 31, 2025 | 62.44 Mn |
| Dec 31, 2024 | 122.33 Mn |
| Sep 30, 2024 | 198.80 Mn |
| Jun 30, 2024 | 313.57 Mn |
| Mar 31, 2024 | 284.15 Mn |
| Dec 31, 2023 | 260.52 Mn |
| Sep 30, 2023 | 216.51 Mn |
| Jun 30, 2023 | 141.31 Mn |
| Mar 31, 2023 | 101.46 Mn |
| Dec 31, 2022 | 109.96 Mn |
| Sep 30, 2022 | 91.19 Mn |
| Jun 30, 2022 | 115.71 Mn |
| Mar 31, 2022 | 117.04 Mn |
| Dec 31, 2021 | 123.02 Mn |
| Sep 30, 2021 | 136.35 Mn |
API Access
Coherus Oncology Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=CHRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "CHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=CHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();